EMEA MOVES TO BOOST CONTROLS OF NON-EU CLINICAL TRIALS
February 1st, 2009
BY KEITH NUTHALL
INCREASED controls on clinical trials staged outside the European Union (EU) and north America are planned by the European Medicines Agency (EMEA). The EU agency has released a report noting the "growing concern both among regulators and in public debate about how well these trials are conducted from an ethical and scientific/organisational standpoint...and the supervision of these trials." It noted that around 25% of patients used in "pivotal trials submitted between 2005 and 2008" were recruited in Latin America, Asia, the ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.